Abstract:Immunoglobulin Y (IgY) is central to our understanding of immunoglobulin evolution. It has links to antibodies from the ancestral IgM to the mucosal IgX and IgA, as well as to mammalian serum IgG and IgE. IgY is found in amphibians, birds and reptiles, and as their most abundant serum antibody, is orthologous to mammalian IgG. However, IgY has the same domain architecture as IgM and IgE, lacking a hinge region and comprising four heavy-chain constant domains. The relationship between IgY and the mucosal antibodies IgX and IgA is discussed herein, in particular the question of how IgA could have contributed to the emergence of IgY. Although IgY does not contain a hinge region, amphibian IgF and duck-billed platypus IgY/O, which are closely related to IgY, do contain this region, as does mammalian IgG, IgA and IgD. A hinge region must therefore have evolved at least three times independently by convergent evolution. In the absence of three-dimensional structural information for the complete Fc fragment of chicken IgY (IgY-Fc), it remains to be discovered whether IgY displays the same conformational properties as IgM and IgE, which exhibit substantial flexibility in their Fc regions. IgY has three characterised Fc receptors, chicken Ig-like receptor AB1 (CHIR-AB1), the chicken yolk sac IgY receptor (FcRY) and Gallus gallus Fc receptor (ggFcR). These receptors bind to IgY at sites that are structurally homologous to mammalian counterparts; IgA/FcαRI for CHIR-AB1, IgG/FcRn for FcRY and IgE/FcϵRI and IgG/FcγR for ggFcR. These resemblances reflect the close evolutionary relationships between IgY and IgA, IgG and IgE. However, the evolutionary distance between birds and mammals allows for the ready generation of IgY antibodies to conserved mammalian proteins for medical and biotechnological applications. Furthermore, the lack of reactivity of IgY with mammalian Fc receptors, and the fact that large quantities of IgY can be made quickly and cheaply in chicken eggs, offers important advantages and considerable potential for IgY in research, diagnostics and therapeutics.

Applications of IgY in Human Medicine

IgY antibodies for the immunoprophylaxis and therapy of respiratory infections

Perspectives on IgY Technology

Egg yolk antibodies (IgY) and their applications in human and veterinary health: A review

Use of Immunoglobulin Y Antibodies: Biosensor-based Diagnostic Systems and Prophylactic and Therapeutic Drug Delivery Systems for Viral Respiratory Diseases

A Comparative and Comprehensive Review of Antibody Applications in the Treatment of Lung Disease

Development of IgY Technology: A Historical Perspective

IgY Delivery and Dosage Form

Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses

Chicken Egg Yolk Antibodies (IgY-technology): A Review of Progress in Production and Use in Research and Human and Veterinary Medicine

Trends in industrialization and commercialization of IgY technology

Recent advances in the molecular understanding of immunoglobulin A

IgY: a key isotype in antibody evolution

IgY Industries and Markets

Immunomodulatory and anti‐inflammatory properties of immunoglobulin G antibodies

A review on the application of chicken immunoglobulin Y in aquaculture

Prophylaxis and therapy of pandemic H1N1 virus infection using egg yolk antibody

SARS-CoV-2-specific Immunoglobulin Y Antibodies Are Protective in Infected Mice

Immunoglobulin A Response to SARS-CoV-2 Infection and Immunity

Chicken egg yolk antibodies (IgY) as non-antibiotic production enhancers for use in swine production: a review

The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro